4//SEC Filing
Elvig Mark F 4
Accession 0001209191-20-008886
CIK 0001000229other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:21 PM ET
Size
5.8 KB
Accession
0001209191-20-008886
Insider Transaction Report
Form 4
Elvig Mark F
VP, Counsel & Secretary
Transactions
- Award
Performance Shares
2020-02-11+12,000→ 12,000 totalExercise: $0.00→ Common Shares (12,000 underlying)
Footnotes (1)
- [F1]This award vests at the end of a three-year performance period that begins on January 1, 2020 and ends on December 31, 2022 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return on Invested Capital of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001435153
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:21 PM ET
- Size
- 5.8 KB